Back to Search
GEORGE PAPAKOSTAS, MD
MD
Psychiatry Physician
NPI: 1588654131Individual
Specialties, Licenses & Credentials
Psychiatry PhysicianPrimary
Psychiatry & Neurology — Psychiatry
Code: 2084P0800X
213347(MA)
Clinical Trials (2)
2
Linked Trials
0
Recruiting
1
With Results
Study of 6(S)-5-MTHF Among Selective Serotonin Reuptake Inhibitor-Resistant Outpatients With Major Depressive Disorder
NCT00955955COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
A Study of 6(S)-5-MTHF Among Serotonin Reuptake Inhibitor(SSRI)-Resistant Outpatients With Major Depressive Disorder (MDD)
NCT00321152COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Research & Publications (20)
Long-term efficacy, safety, and tolerability of L-methylfolate calcium 15 mg as adjunctive therapy with selective serotonin reuptake inhibitors: a 12-month, open-label study following a placebo-controlled acute study.
PMID 27035404·J Clin Psychiatry·2016
2-rct
Association of obesity and inflammatory marker levels on treatment outcome: results from a double-blind, randomized study of adjunctive L-methylfolate calcium in patients with MDD who are inadequate responders to SSRIs.
PMID 26613389·J Clin Psychiatry·2015
2-rct
Effect of adjunctive L-methylfolate 15 mg among inadequate responders to SSRIs in depressed patients who were stratified by biomarker levels and genotype: results from a randomized clinical trial.
PMID 24813065·J Clin Psychiatry·2014
4-observational
L-methylfolate as adjunctive therapy for SSRI-resistant major depression: results of two randomized, double-blind, parallel-sequential trials.
PMID 23212058·Am J Psychiatry·2012
4-observational
5HT1A-mediated stimulation of cortisol release in major depression: use of non-invasive cortisol measurements to predict clinical response.
PMID 19641981·Eur Arch Psychiatry Clin Neurosci·2010
3-trial
Does the probability of receiving placebo influence clinical trial outcome? A meta-regression of double-blind, randomized clinical trials in MDD.
PMID 18823760·Eur Neuropsychopharmacol·2009
1-meta
Pharmacologic and therapeutic strategies in treatment-resistant depression. Switching antidepressants vs. conventional augmentation strategies.
PMID 19407715·CNS Spectr·2009
8-other
Initial treatment approaches for patients with major depressive disorder.
PMID 19573474·J Clin Psychiatry·2009
8-other
Simultaneous initiation (coinitiation) of pharmacotherapy with triiodothyronine and a selective serotonin reuptake inhibitor for major depressive disorder: a quantitative synthesis of double-blind studies.
PMID 19092448·Int Clin Psychopharmacol·2009
4-observational
Psychic and somatic anxiety symptoms as predictors of response to fluoxetine in major depressive disorder.
PMID 18755514·Psychiatry Res·2008
4-observational
Use of atypical antipsychotics for treatment-resistant major depressive disorder.
PMID 18980731·Curr Psychiatry Rep·2008
6-review
A meta-analysis of clinical trials comparing reboxetine, a norepinephrine reuptake inhibitor, with selective serotonin reuptake inhibitors for the treatment of major depressive disorder.
PMID 17719752·Eur Neuropsychopharmacol·2008
1-meta
Efficacy of bupropion and the selective serotonin reuptake inhibitors in the treatment of major depressive disorder with high levels of anxiety (anxious depression): a pooled analysis of 10 studies.
PMID 18605812·J Clin Psychiatry·2008
8-other
Predictors, moderators, and mediators (correlates) of treatment outcome in major depressive disorder.
PMID 19170401·Dialogues Clin Neurosci·2008
6-review
Treatment of SSRI-resistant depression: a meta-analysis comparing within- versus across-class switches.
PMID 17919460·Biol Psychiatry·2008
1-meta
A meta-analysis of clinical trials comparing mirtazapine with selective serotonin reuptake inhibitors for the treatment of major depressive disorder.
PMID 18308801·J Psychopharmacol·2008
1-meta
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 55 FRUIT ST, S50 4 MASSACHUSETTS GENERAL HOSPITAL
BOSTON, MA 02114 - Phone
- (617) 726-6697
Quick Facts
- NPI
- 1588654131
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Clinical Trials
- 2
- Publications
- 20
Are you this provider?
Claim Your Profile